Sanara MedTech (SMTI) Competitors $34.11 +0.43 (+1.28%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMTI vs. EMBC, CBLL, LQDA, EYE, BVS, FNA, AVNS, BFLY, IRMD, and AXGNShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Embecta (EMBC), CeriBell (CBLL), Liquidia (LQDA), National Vision (EYE), Bioventus (BVS), Paragon 28 (FNA), Avanos Medical (AVNS), Butterfly Network (BFLY), Iradimed (IRMD), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Embecta CeriBell Liquidia National Vision Bioventus Paragon 28 Avanos Medical Butterfly Network Iradimed AxoGen Embecta (NASDAQ:EMBC) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings. Is EMBC or SMTI more profitable? Embecta has a net margin of 6.97% compared to Sanara MedTech's net margin of -10.71%. Embecta's return on equity of -18.54% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Embecta6.97% -18.54% 11.43% Sanara MedTech -10.71%-19.86%-10.91% Which has more volatility & risk, EMBC or SMTI? Embecta has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Do insiders and institutionals have more ownership in EMBC or SMTI? 93.8% of Embecta shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 0.3% of Embecta shares are owned by insiders. Comparatively, 54.1% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor EMBC or SMTI? In the previous week, Embecta had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 4 mentions for Embecta and 3 mentions for Sanara MedTech. Embecta's average media sentiment score of 1.13 beat Sanara MedTech's score of 0.00 indicating that Embecta is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Embecta 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, EMBC or SMTI? Embecta has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEmbecta$1.12B1.06$78.30M$1.3515.10Sanara MedTech$78.06M3.82-$4.30M-$0.99-34.45 Do analysts recommend EMBC or SMTI? Embecta currently has a consensus target price of $23.00, indicating a potential upside of 12.80%. Sanara MedTech has a consensus target price of $47.00, indicating a potential upside of 37.79%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than Embecta.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Embecta 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor EMBC or SMTI? Sanara MedTech received 18 more outperform votes than Embecta when rated by MarketBeat users. Likewise, 55.88% of users gave Sanara MedTech an outperform vote while only 6.25% of users gave Embecta an outperform vote. CompanyUnderperformOutperformEmbectaOutperform Votes16.25%Underperform Votes1593.75% Sanara MedTechOutperform Votes1955.88% Underperform Votes1544.12% SummaryEmbecta beats Sanara MedTech on 10 of the 18 factors compared between the two stocks. Ad DTIForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedMake sure to check out Gamma Pockets HERE while it’s still widely available Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$298.16M$9.54B$5.20B$9.14BDividend YieldN/A1.40%5.12%4.29%P/E Ratio-34.4519.4487.0517.14Price / Sales3.8232.751,138.53122.78Price / CashN/A22.3743.2337.84Price / Book6.535.574.804.78Net Income-$4.30M$182.72M$120.46M$225.43M7 Day Performance0.83%-4.63%-0.84%-0.68%1 Month Performance-9.52%-6.24%14.79%1.03%1 Year Performance-10.87%-14.07%29.53%15.71% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.4953 of 5 stars$34.11+1.3%$47.00+37.8%-12.0%$298.16M$78.06M-34.4560Analyst ForecastNews CoverageGap UpEMBCEmbecta4.0699 of 5 stars$19.84+1.7%$23.00+15.9%+10.1%$1.15B$1.12B14.712,200Positive NewsCBLLCeriBellN/A$29.04-0.6%$32.60+12.3%N/A$1.04B$60.04M0.00N/ANews CoverageLQDALiquidia3.2787 of 5 stars$11.07+1.4%$24.00+116.8%-5.7%$936.93M$15.61M-6.7050Analyst ForecastEYENational Vision3.7048 of 5 stars$11.59+1.6%$14.00+20.8%-41.9%$912.71M$2.13B-57.0513,998Positive NewsBVSBioventus3.6094 of 5 stars$11.17+1.3%$16.00+43.2%+104.0%$906.50M$555.06M-18.081,200Positive NewsFNAParagon 283.0662 of 5 stars$10.60+1.7%$15.60+47.2%-19.6%$887.43M$245.00M-14.08343,000AVNSAvanos Medical2.8921 of 5 stars$17.88-0.5%N/A-29.5%$821.77M$673.30M52.853,771BFLYButterfly Network0.5898 of 5 stars$3.65+7.7%$3.00-17.8%+192.9%$777.68M$76.22M-7.37460IRMDIradimed4.505 of 5 stars$53.06+0.8%$60.00+13.1%+18.0%$672.27M$65.56M36.05110AXGNAxoGen1.0895 of 5 stars$14.45+2.0%$15.00+3.8%+123.4%$635.92M$180.86M-44.47426Positive NewsGap Up Related Companies and Tools Related Companies Embecta Competitors CeriBell Competitors Liquidia Competitors National Vision Competitors Bioventus Competitors Paragon 28 Competitors Avanos Medical Competitors Butterfly Network Competitors Iradimed Competitors AxoGen Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMTI) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMTI Stock Alerts